← Scroll for more →
Financial Statements — CRML
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|
| Cash & Equivalents | 80.92 | 7.30 | 0.15 | 1.26 |
| Total Current Assets | 80.97 | 8.31 | 0.55 | 3.74 |
| Total Non-current Assets | 186.33 | 163.41 | 145.78 | 55.61 |
| Total Assets | 267.30 | 171.72 | 146.33 | 59.35 |
| Total Current Liabilities | 108.41 | 64.79 | 54.21 | 55.39 |
| Total Non-current Liabilities | 15.01 | 15.01 | 15.02 | 15.02 |
| Total Liabilities | 123.42 | 79.80 | 69.23 | 70.42 |
| Retained Earnings | (320.93) | (200.56) | (167.62) | (148.69) |
| Total Stockholder Equity | 143.88 | 91.92 | 77.10 | (11.07) |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Total Revenue | -- | 0.36 | -- |
| Cost of Revenue* | -- | (124.64) | -- |
| Gross Profit | -- | 125.00 | 125.00 |
| Selling, General & Admin | 1.18 | 0.18 | -- |
| Interest Expense | -- | -- | 1.00 |
| Pretax Income | (120.38) | (18.94) | -- |
| Net Income | (120.38) | (18.94) | -- |
| Basic EPS | (1.07) | (0.21) | -- |
| Diluted EPS | (1.07) | (0.21) | -- |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Operating Cash Flow | (19.16) | (2.59) |
| Investing Cash Flow | (6.86) | (1.33) |
| Financing Cash Flow | 99.62 | 2.44 |
← Scroll for more columns →